report
addit
recapitul
classic
human
gaucher
diseas
phenotyp
delet
glucocerebrosidas
gene
mice
result
dysfunct
divers
popul
immun
cell
immunerel
nonclass
featur
includ
gammopathi
autoimmun
diathesi
resist
macrophagedirect
therapi
prompt
search
newer
agent
human
use
highdens
microarray
splenic
liver
cell
affect
mice
establish
gene
signatur
util
interrog
broad
institut
databas
cmap
comput
connect
map
diseas
drug
pair
cmap
reveal
sever
highli
enrich
nonnul
mimic
antimim
hit
notabl
two
compound
antihelminth
properti
name
albendazol
oxamniquin
identifi
particularli
relev
futur
test
express
chitinas
enhanc
gaucher
diseas
archetyp
lysosom
storag
disord
result
defect
activ
acid
aris
biallel
mutat
gene
phenotyp
present
divers
display
imperfect
correl
mutat
mainli
due
modifi
gene
specif
certain
diseas
patholog
malign
gammopathi
autoimmun
diathesi
parkinson
diseas
osteoporosi
explain
lysosom
accumul
lipid
substrat
macrophag
inde
shown
mice
lack
gene
recapitul
viscer
manifest
includ
hepatosplenomegali
marrow
infiltr
extramedullari
hematopoiesi
also
present
widespread
dysfunct
unexpect
immun
cell
popul
despit
new
inform
know
clinic
studi
nonclass
clinic
featur
gd
resist
macrophagedirect
enzym
replac
therapi
prompt
explor
potenti
molecul
treatment
gd
attempt
drug
discoveri
tradit
util
highthroughput
screen
small
molecul
librari
contrast
connect
map
cmap
wwwbroadmiteducmap
rapid
silico
techniqu
studi
connect
mechan
drug
action
consequ
genet
perturb
molecular
aberr
diseas
state
supersed
gene
profil
use
elucid
biolog
pathway
reveal
cryptic
diseas
subtyp
new
approach
employ
diseas
drug
gene
signatur
queri
databas
compris
gene
express
profil
nonparametr
rankbas
patternmatch
use
kolmogorovsmirnov
statist
reveal
compound
share
mechan
overlap
given
diseas
genet
perturb
compound
subsequ
test
biolog
activ
potenti
lead
molecul
current
studi
first
develop
queri
signatur
high
densiti
microarray
profil
spleen
liver
cell
obtain
wild
type
mice
interrog
cmap
pathwaybas
queri
signatur
yield
hierarch
list
novel
compound
share
common
mechan
compound
test
biolog
activ
vitro
vivo
mice
use
previous
publish
dataset
mous
gene
delet
cell
hematopoiet
mesenchym
lineag
mice
exhibit
differ
phenotyp
sever
classifi
sever
mildmoder
base
foldincreas
spleen
size
compar
control
unaffect
mice
figur
show
overal
approach
select
affect
gene
filter
connect
map
gene
express
pattern
liver
spleen
profil
use
genechip
mous
gene
st
array
affymetrix
santa
clara
ca
analyz
bioconductor
genechip
robust
multiarray
averag
gcrma
packag
dataset
avail
nation
center
biotechnolog
inform
ncbi
gene
express
omnibu
geo
access
number
gene
satisfi
follow
criteria
select
queri
ingenu
pathway
analysi
ipa
ingenu
system
redwood
citi
ca
express
pattern
follow
progress
chang
ie
sever
mildmoder
control
upor
downregul
gene
sever
mous
show
chang
compar
control
ipa
pathway
analysi
gene
constitut
signific
network
ie
lowest
pvalu
select
howev
select
gene
present
origin
queri
mere
connect
molecul
within
network
therefor
use
stringent
filter
criteria
ipaanalyz
gene
name
express
pattern
must
follow
progress
chang
upor
downregul
gene
mildmoder
mous
must
show
chang
compar
control
mice
note
criteria
stringent
latter
comparison
made
control
mildlymoder
affect
mice
spleen
size
multipl
normal
wherea
initi
screen
control
mice
compar
sever
affect
anim
spleen
size
multipl
normal
set
gene
name
liver
upregul
liver
downregul
spleen
upregul
spleen
downregul
translat
respect
affymetrix
genechip
human
probe
set
name
use
queri
signatur
analysi
cmap
connect
map
build
http
wwwbroadinstituteorgcmap
result
cmap
analysi
rank
first
enrich
percent
nonnul
discard
hit
pvalu
hit
number
instanc
n
smaller
probe
set
mous
gene
st
array
use
threshold
found
upregul
downregul
gene
liver
upregul
downregul
gene
spleen
sever
compar
control
supplementari
tabl
interrog
ipa
gene
set
yield
sever
signific
network
supplementari
tabl
liver
upregul
gene
compris
inflammatori
respons
immun
gene
wherea
lipid
metabol
fatti
acid
metabol
gene
downregul
contrast
gene
pathway
upregul
spleen
includ
infecti
diseas
sever
acut
respiratori
syndrom
gene
wherea
downregul
compris
gene
relat
hematolog
system
develop
function
quantiti
lymphocyt
gene
express
pattern
deciph
broadli
similar
report
anoth
mous
model
data
biolog
plausibl
view
recent
observ
plethora
immun
cell
defect
mice
gene
delet
hematopoiet
stem
cell
hsc
notabl
found
thymu
exhibit
earliest
strike
alter
suggest
impair
tcell
matur
aberr
bcell
recruit
enhanc
antigen
present
contrast
spleen
show
less
impress
chang
immun
cell
composit
chang
restrict
mainli
sever
sick
mice
thu
argu
genet
aberr
immun
gene
express
reveal
high
densiti
microarray
might
preced
perhap
even
underli
cellular
composit
chang
note
spleen
prelud
futur
studi
human
evalu
whether
queri
signatur
could
perhap
even
assign
predict
immunerel
manifest
note
macrophagetarget
enzym
replac
therapi
amelior
particular
immunolog
skelet
manifest
therefor
elect
develop
spleenand
liverbas
queri
signatur
interrog
cmap
yield
compound
amen
test
filter
gene
set
contain
within
upregul
downregul
pathway
note
supplementari
tabl
specif
remov
gene
regul
origin
dataset
figur
supplementari
tabl
tabl
show
number
gene
filter
gene
set
use
signatur
queri
cmap
tabl
show
signific
hit
cmap
analysi
chemic
structur
hit
shown
supplementari
figur
note
data
rank
first
enrich
percent
nonnul
hit
criteria
differ
use
previous
wherein
connect
score
sole
determin
cmap
rank
line
inflammatori
immun
gene
regul
cmap
yield
host
chemic
util
acut
chronic
infect
one
high
score
hit
albendazol
enrich
p
n
use
antihelminth
agent
cysticercosi
interestingli
highest
rank
antimim
oxamniquin
antihelminth
agent
schistosomiasi
notabl
respons
macrophag
accumul
major
minor
lyso
lipid
substrat
aris
defici
interest
parallel
infect
chitincontain
parasit
organ
exampl
addit
trend
toward
altern
macrophag
polar
respons
impress
product
chitinas
chitinaselik
protein
fact
massiv
upregul
chitotriosidas
lipidladen
gaucher
cell
elev
serum
level
human
likewis
report
increas
express
chitinas
chitinas
liver
spleen
mice
prompt
futur
test
antihelminth
agent
albendazol
oxamniquin
similar
exampl
drugdiseas
pair
use
inflammatori
bowel
diseas
ibd
gene
signatur
led
identif
topiram
anticonvuls
effect
agent
ibd
likewis
shown
use
cmap
certain
hdac
inhibitor
mechanist
overlap
select
estrogen
receptor
modul
addit
antihelminth
anoth
notabl
highrank
antimim
liver
cmap
output
fendilin
enrich
p
calcium
channel
blocker
latter
class
drug
alreadi
explor
therapeut
potenti
final
particular
pattern
cmap
mimic
antimim
spleen
rang
histamin
releas
blocker
skimmianin
calciumcalmodulin
inhibitor
thu
comput
genom
connect
map
provid
uniqu
purpos
strategi
unravel
new
action
drug
current
use
medic
condit
well
new
therapeut
old
diseas
given
therapeut
armamentarium
small
enzym
replac
therapi
revers
manifest
would
worthwhil
investig
highrank
cmap
output
biolog
activ
defici
mice
refer
web
version
pubm
central
supplementari
materi
queri
signatur
gener
microarray
profil
pathway
analysi
mice
cmap
analysi
use
signatur
queri
yield
mimic
antimim
two
antihelminth
particularli
relev
identifi
use
approach
schemat
diagram
show
approach
drug
mimicantimim
identif
util
combin
techniqu
name
microarray
gene
profil
pathway
analysi
connect
map
pathwayenrich
gene
show
b
regul
liver
sever
mice
pathway
analysi
gene
select
show
least
c
regul
liver
mild
mice
pathwayenrich
gene
show
b
regul
spleen
sever
mice
pathway
analysi
gene
select
show
least
c
regul
spleen
moder
mice
number
gene
constitut
signific
network
ipa
pathway
analysi
filter
regul
mildmoder
mous
signific
hit
mous
liver
spleen
cmap
analysi
signific
hit
mimic
antimim
mous
liver
spleen
cmap
analysi
shown
mean
connect
score
number
instanc
n
enrich
score
pvalu
specif
score
percent
nonnul
known
biolog
action
compound
state
pleas
refer
supplementari
figur
chemic
structur
